Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been given a consensus recommendation of "Hold" by the seven ratings firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $20.08.
Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th.
Read Our Latest Report on OSCR
Insider Activity at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 24.39% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Oscar Health
Several institutional investors and hedge funds have recently bought and sold shares of OSCR. Barclays PLC grew its holdings in Oscar Health by 217.5% during the third quarter. Barclays PLC now owns 325,818 shares of the company's stock valued at $6,911,000 after purchasing an additional 223,189 shares during the period. Hennessy Advisors Inc. grew its holdings in Oscar Health by 550.3% during the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the period. Rolek Wealth Management LLC bought a new position in shares of Oscar Health in the fourth quarter worth $208,000. Janney Montgomery Scott LLC boosted its holdings in shares of Oscar Health by 24.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 57,850 shares of the company's stock worth $778,000 after acquiring an additional 11,282 shares during the period. Finally, Whalen Wealth Management Inc. bought a new position in shares of Oscar Health in the fourth quarter worth $670,000. 75.70% of the stock is owned by institutional investors.
Oscar Health Stock Performance
Shares of Oscar Health stock opened at $17.52 on Friday. The company has a market cap of $4.39 billion, a PE ratio of -875.31 and a beta of 1.75. Oscar Health has a 52 week low of $11.20 and a 52 week high of $23.79. The business has a 50 day moving average price of $13.46 and a 200-day moving average price of $14.66. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company's quarterly revenue was up 42.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.62 earnings per share. Equities analysts anticipate that Oscar Health will post 0.69 earnings per share for the current fiscal year.
Oscar Health Company Profile
(
Get Free ReportOscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.